Gamble Jones Investment Counsel lessened its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,084 shares of the healthcare conglomerate’s stock after selling 650 shares during the period. Gamble Jones Investment Counsel’s holdings in UnitedHealth Group were worth $2,885,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of the company. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of UnitedHealth Group by 2.0% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,213,982 shares of the healthcare conglomerate’s stock valued at $708,554,000 after acquiring an additional 62,840 shares in the last quarter. Concentric Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $220,000. Bank of The West raised its stake in shares of UnitedHealth Group by 6.2% during the fourth quarter. Bank of The West now owns 43,346 shares of the healthcare conglomerate’s stock valued at $9,556,000 after acquiring an additional 2,528 shares in the last quarter. Loeb Partners Corp raised its stake in shares of UnitedHealth Group by 184.3% during the fourth quarter. Loeb Partners Corp now owns 19,900 shares of the healthcare conglomerate’s stock valued at $4,388,000 after acquiring an additional 12,900 shares in the last quarter. Finally, Aries Wealth Management bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $202,000. 86.78% of the stock is owned by hedge funds and other institutional investors.
In other news, insider Larry C. Renfro sold 22,184 shares of UnitedHealth Group stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the sale, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the sale, the director now owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The disclosure for this sale can be found here. Insiders have sold 67,015 shares of company stock valued at $15,635,599 over the last quarter. Insiders own 0.89% of the company’s stock.
UNH stock opened at $226.78 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 1-year low of $162.74 and a 1-year high of $250.79. The stock has a market cap of $220,491.67, a price-to-earnings ratio of 21.17, a price-to-earnings-growth ratio of 1.33 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period in the previous year, the company earned $2.11 earnings per share. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. sell-side analysts anticipate that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were paid a dividend of $0.75 per share. The ex-dividend date was Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.32%. UnitedHealth Group’s payout ratio is currently 28.01%.
Several analysts have recently weighed in on UNH shares. Cantor Fitzgerald reissued a “buy” rating and set a $225.00 price objective on shares of UnitedHealth Group in a report on Monday, November 27th. Wells Fargo reissued an “outperform” rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company an “outperform” rating in a report on Wednesday, November 29th. Credit Suisse Group reissued a “positive” rating and set a $240.00 price objective (up from $233.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, Royal Bank of Canada lifted their price objective on shares of UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $245.14.
WARNING: This story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://ledgergazette.com/2018/03/21/unitedhealth-group-inc-unh-shares-sold-by-gamble-jones-investment-counsel.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.